Sergey A Evfratov

Lomonosov Moscow State University

Papers

1

Total Citations

3

H-Index

1

About

Sergey A. Evfratov is a molecular biologist whose work centers on protein biosynthesis and antibiotic discovery. His primary research focuses on developing high-throughput screening platforms to identify novel inhibitors of bacterial protein synthesis, a critical strategy in combating antimicrobial resistance. His most cited work, a 2016 study on a high-throughput screening platform for new inhibitors of protein biosynthesis, has garnered 3 citations and represents a significant methodological contribution. This platform enables the rapid testing of thousands of compounds while simultaneously elucidating their mechanisms of antimicrobial action, bridging a crucial gap between basic research and clinical application. Evfratov’s approach is distinguished by its dual emphasis on efficiency and mechanistic clarity, allowing researchers to not only identify potential antibiotics but also understand how they disrupt protein synthesis at the molecular level. His contributions are particularly relevant for healthcare practices, where the urgent need for new antimicrobial agents demands innovative screening technologies. Through his work, Evfratov has advanced the toolkit for antibiotic discovery, offering a scalable solution to one of modern medicine’s most pressing challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
High throughput screening platform for new inhibitors of protein biosynthesis
3 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Lomonosov Moscow State University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago